The Menopause Society (2026) 20 - 24 October 2026

Effect of CagriSema on body weight reduction and cardiometabolic risk factors in women by menopause status and hormone therapy use: A post hoc analysis of the REDEFINE 1 trial

Authors :

Maria D. Hurtado Andrade¹; Camila Martins Mazini Tavares²; Cynthia K. O. Contreras²; Anthony Fabricatore³; Emilia Huvinen⁴;Vandana Yadav⁵; Nanette F. Santoro⁶

Affiliations

View Details Hide Details

Download the poster (.pdf)

Keywords

Obesity

Congress poster

Amylin

CagriSema

PHASE 3 (RCT)

Search Science Hub

Are you a healthcare professional?

Effect of CagriSema on body weight reduction and cardiometabolic risk factors in women by menopause status and hormone therapy use: A post hoc analysis of the REDEFINE 1 trial